Skip to main content
Business

SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss

SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss

Feed excerpt — reported by Inc.

SheMed’s study of more than 8,000 women found improvements in weight, blood sugar, and cholesterol. Its founders believe that’s just the start of what GLP-1 research could uncover.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Inc. →

Original Source

This article was syndicated from Inc.. All rights remain with the original publisher.